Life Science Intelligence (LSI) has entered a multi-year partnership with Mednovation to leverage its events, market intelligence products, research services and other strategic initiatives in China, a press release reported.
“We are thrilled to join forces with LSI and become their preferred partner in China,” Partner at Mednovation, William Jin, said. “The cooperation between our companies will help us best support LSI’s global expansion efforts, medtech leaders that are exploring the Chinese market, medtech leaders in the Chinese market today and the members of Mednovation seeking to access international markets and resources.”
According to the conditions of the partnership, Mednovation will now contribute to LSI’s catalog of Medtech Summits across North America and Europe, and introduce the initiative to other markets worldwide.
“China’s ecosystem presents a tremendous opportunity to advance medtech innovation and continue our efforts toward saving patient lives and improving the standard of care globally,” CEO of LSI, Scott Pantel, said. “With partnering events and market intelligence services trusted by global medtech leaders, we are excited to take another step in expanding our community. We look forward to working with Mednovation to engage, support and develop China’s active medtech innovation ecosystem.”
The news is confirmed after the company’s first-ever Emerging Medtech Summit outside of the U.S, “LSI Europe 2022,” featuring Bernd Montag, CEO of Siemens Healthineers and Antoine Papiernik, managing partner of Sofinnova Partners.